ID AL1L2_HUMAN Reviewed; 923 AA. AC Q3SY69; Q3SY68; Q68D62; Q6AI55; Q8N922; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 15-JAN-2008, sequence version 2. DT 07-JUL-2009, entry version 38. DE RecName: Full=Probable 10-formyltetrahydrofolate dehydrogenase ALDH1L2; DE EC=1.5.1.6; DE AltName: Full=Aldehyde dehydrogenase family 1 member L2; GN Name=ALDH1L2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-752 (ISOFORM 1). RC TISSUE=Chondrocyte; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 221-511 (ISOFORM 3), AND RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 762-923 (ISOFORM 1). RC TISSUE=Cervix, and Uterus; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Blocker H., RA Heubner D., Hoerlein A., Michel G., Wedler H., Kohrer K., RA Ottenwalder B., Poustka A., Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). CC -!- CATALYTIC ACTIVITY: 10-formyltetrahydrofolate + NADP(+) + H(2)O = CC tetrahydrofolate + CO(2) + NADPH. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q3SY69-1; Sequence=Displayed; CC Name=2; CC IsoId=Q3SY69-2; Sequence=VSP_030752, VSP_030753; CC Note=No experimental confirmation available; CC Name=3; CC IsoId=Q3SY69-3; Sequence=VSP_030754, VSP_030755; CC Note=No experimental confirmation available; CC -!- SIMILARITY: In the N-terminal section; belongs to the GART family. CC -!- SIMILARITY: In the C-terminal section; belongs to the aldehyde CC dehydrogenase family. ALDH1L subfamily. CC -!- SIMILARITY: Contains 1 acyl carrier domain. CC -!- SEQUENCE CAUTION: CC Sequence=AAI03936.1; Type=Erroneous translation; Note=Wrong choice of CDS; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; BC103934; AAI03935.1; -; mRNA. DR EMBL; BC103935; AAI03936.1; ALT_SEQ; mRNA. DR EMBL; AK095827; BAC04634.1; -; mRNA. DR EMBL; CR627287; CAH10368.1; ALT_TERM; mRNA. DR EMBL; CR749561; CAH18358.1; -; mRNA. DR IPI; IPI00298308; -. DR IPI; IPI00878398; -. DR IPI; IPI00878818; -. DR RefSeq; NP_001029345.1; -. DR UniGene; Hs.42572; -. DR SMR; Q3SY69; 426-923. DR PRIDE; Q3SY69; -. DR Ensembl; ENSG00000136010; Homo sapiens. DR GeneID; 160428; -. DR KEGG; hsa:160428; -. DR UCSC; uc001tlc.1; human. DR GeneCards; GC12M103921; -. DR HGNC; HGNC:26777; ALDH1L2. DR PharmGKB; PA134928545; -. DR HOGENOM; Q3SY69; -. DR HOVERGEN; Q3SY69; -. DR OMA; Q3SY69; PLEIKGA. DR BRENDA; 1.5.1.6; 247. DR NextBio; 87968; -. DR ArrayExpress; Q3SY69; -. DR CleanEx; HS_ALDH1L2; -. DR GO; GO:0005737; C:cytoplasm; IEA:InterPro. DR GO; GO:0000036; F:acyl carrier activity; IEA:InterPro. DR GO; GO:0016155; F:formyltetrahydrofolate dehydrogenase activity; IEA:EC. DR GO; GO:0016742; F:hydroxymethyl-, formyl- and related transfe...; IEA:InterPro. DR GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro. DR GO; GO:0009258; P:10-formyltetrahydrofolate catabolic process; IEA:InterPro. DR GO; GO:0009058; P:biosynthetic process; IEA:InterPro. DR GO; GO:0006730; P:one-carbon compound metabolic process; IEA:UniProtKB-KW. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR InterPro; IPR011407; 10_FTHF_DH. DR InterPro; IPR009081; Acyl_carrier_prot-like. DR InterPro; IPR016160; Ald_DH_CS. DR InterPro; IPR016162; Ald_DH_N. DR InterPro; IPR015590; Aldehyde_DH. DR InterPro; IPR005793; Formyl_trans_C. DR InterPro; IPR002376; Formyl_transf_N. DR InterPro; IPR001555; GART_AS. DR InterPro; IPR006162; Ppantne_S. DR Gene3D; G3DSA:3.40.605.10; Aldehyde_dehydrogenase_N; 1. DR Gene3D; G3DSA:3.10.25.10; Formyl_trans_C; 1. DR Gene3D; G3DSA:3.40.50.170; Formyl_transf_N; 1. DR PANTHER; PTHR11699; Aldehyde_dehyd; 1. DR Pfam; PF00171; Aldedh; 1. DR Pfam; PF02911; Formyl_trans_C; 1. DR Pfam; PF00551; Formyl_trans_N; 1. DR PIRSF; PIRSF036489; 10-FTHFDH; 1. DR PROSITE; PS50075; ACP_DOMAIN; 1. DR PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1. DR PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1. DR PROSITE; PS00373; GART; 1. DR PROSITE; PS00012; PHOSPHOPANTETHEINE; 1. PE 2: Evidence at transcript level; KW Alternative splicing; Complete proteome; NADP; One-carbon metabolism; KW Oxidoreductase; Phosphopantetheine. FT CHAIN 1 923 Probable 10-formyltetrahydrofolate FT dehydrogenase ALDH1L2. FT /FTId=PRO_0000316001. FT DOMAIN 344 413 Acyl carrier. FT REGION 23 225 GART. FT REGION 438 923 Aldehyde dehydrogenase. FT ACT_SITE 128 128 Proton donor (By similarity). FT ACT_SITE 694 694 By similarity. FT ACT_SITE 728 728 By similarity. FT SITE 164 164 Essential for catalytic activity (By FT similarity). FT MOD_RES 375 375 O-(pantetheine 4'-phosphoryl)serine (By FT similarity). FT VAR_SEQ 199 203 VEAVQ -> KLSNS (in isoform 2). FT /FTId=VSP_030752. FT VAR_SEQ 204 923 Missing (in isoform 2). FT /FTId=VSP_030753. FT VAR_SEQ 512 516 RLADL -> SMRMN (in isoform 3). FT /FTId=VSP_030754. FT VAR_SEQ 517 923 Missing (in isoform 3). FT /FTId=VSP_030755. FT CONFLICT 712 712 A -> T (in Ref. 1; AAI03935). SQ SEQUENCE 923 AA; 101746 MW; C5DD74506F08AAFE CRC64; MLRRGSQALR RFSTGRVYFK NKLKLALIGQ SLFGQEVYSH LRKEGHRVVG VFTVPDKDGK ADPLALAAEK DGTPVFKLPK WRVKGKTIKE VAEAYRSVGA ELNVLPFCTQ FIPMDIIDSP KHGSIIYHPS ILPRHRGASA INWTLIMGDK KAGFSVFWAD DGLDTGPILL QRSCDVEPND TVDALYNRFL FPEGIKAMVE AVQLIADGKA PRIPQPEEGA TYEGIQKKEN AEISWDQSAE VLHNWIRGHD KVPGAWTEIN GQMVTFYGST LLNSSVPPGE PLEIKGAKKP GLVTKNGLVL FGNDGKALTV RNLQFEDGKM IPASQYFSTG ETSVVELTAE EVKVAETIKV IWAGILSNVP IIEDSTDFFK SGASSMDVAR LVEEIRQKCG GLQLQNEDVY MATKFEGFIQ KVVRKLRGED QEVELVVDYI SKEVNEIMVK MPYQCFINGQ FTDADDGKTY DTINPTDGST ICKVSYASLA DVDKAVAAAK DAFENGEWGR MNARERGRLM YRLADLLEEN QEELATIEAL DSGAVYTLAL KTHIGMSVQT FRYFAGWCDK IQGSTIPINQ ARPNRNLTFT KKEPLGVCAI IIPWNYPLMM LAWKSAACLA AGNTLVLKPA QVTPLTALKF AELSVKAGFP KGVINIIPGS GGIAGQRLSE HPDIRKLGFT GSTPIGKQIM KSCAVSNLKK VSLELGGKSP LIIFNDCELD KAVRMGMGAV FFNKGENCIA AGRLFVEESI HDEFVTRVVE EIKKMKIGDP LDRSTDHGPQ NHKAHLEKLL QYCETGVKEG ATLVYGGRQV QRPGFFMEPT VFTDVEDYMY LAKEESFGPI MVISKFQNGD IDGVLQRANS TEYGLASGVF TRDINKAMYV SEKLEAGTVF INTYNKTDVA APFGGVKQSG FGKDLGEEAL NEYLKTKTVT LEY //